The information provided by two of the excluded articles could only be used to calculate the relative risk (RR) [21, 22]: one found no association between TIMP-2 expression and outcome [21]; the other concluded that TIMP-2 was a harmful factor in NSCLC patients [22]. The gene discussed is TIMP2; the disease is non-small cell lung carcinoma.